These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Special feature of mixed phosphotriester derivatives of cytarabine. Gouy MH; Jordheim LP; Lefebvre I; Cros E; Dumontet C; Peyrottes S; Périgaud C Bioorg Med Chem; 2009 Sep; 17(17):6340-7. PubMed ID: 19674903 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and study of a new series of phosphoramidate derivatives as mononucleotide prodrugs. Egron D; Périgaud C; Gosselin G; Aubertin AM; Imbach JL Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):751-4. PubMed ID: 11563108 [TBL] [Abstract][Full Text] [Related]
11. Prodrugs of Nucleoside 5'-Monophosphate Analogues: Overview of the Recent Literature Concerning their Synthesis and Applications. Roy B; Navarro V; Peyrottes S Curr Med Chem; 2023; 30(11):1256-1303. PubMed ID: 36093825 [TBL] [Abstract][Full Text] [Related]
12. Reactive cyclic intermediates in the ProTide prodrugs activation: trapping the elusive pentavalent phosphorane. Procházková E; Navrátil R; Janeba Z; Roithová J; Baszczyňski O Org Biomol Chem; 2019 Jan; 17(2):315-320. PubMed ID: 30543240 [TBL] [Abstract][Full Text] [Related]
13. Antineoplastic agents 453. Synthesis of pancratistatin prodrugs. Pettit GR; Orr B; Ducki S Anticancer Drug Des; 2000 Dec; 15(6):389-95. PubMed ID: 11716431 [TBL] [Abstract][Full Text] [Related]
14. Synthetic approaches to a mononucleotide prodrug of cytarabine. Bazzanini R; Gouy MH; Peyrottes S; Gosselin G; Périgaud C; Manfredini S Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1635-49. PubMed ID: 16438040 [TBL] [Abstract][Full Text] [Related]
15. An alternative pathway to ribonucleoside β-hydroxyphosphonate analogues and related prodrugs. Hospital A; Meurillon M; Peyrottes S; Périgaud C Org Lett; 2013 Sep; 15(18):4778-81. PubMed ID: 24015803 [TBL] [Abstract][Full Text] [Related]
16. Prodrugs of Ara-CMP and Ara-AMP with a S-acyl-2-thioethyl (SATE) biolabile phosphate protecting group: synthesis and biological evaluation. Bazzanini R; Manfredini S; Durini E; Gröschel B; Cinatl J; Balzarini J; De Clercq E; Imbach JL; Périgaud C; Gosselin G Nucleosides Nucleotides; 1999; 18(4-5):971-2. PubMed ID: 10432722 [TBL] [Abstract][Full Text] [Related]
17. Intracellular trapping of cycloSal-pronucleotides: modification of prodrugs with amino acid esters. Jessen HJ; Balzarini J; Meier C J Med Chem; 2008 Oct; 51(20):6592-8. PubMed ID: 18826203 [TBL] [Abstract][Full Text] [Related]
18. Neighboring group catalysis in the design of nucleotide prodrugs. Khamnei S; Torrence PF J Med Chem; 1996 Sep; 39(20):4109-15. PubMed ID: 8831776 [TBL] [Abstract][Full Text] [Related]
19. New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy. Gosselin G; Girardet JL; Périgaud C; Benzaria S; Lefebvre I; Schlienger N; Pompon A; Imbach JL Acta Biochim Pol; 1996; 43(1):196-208. PubMed ID: 8790724 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs. Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]